Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Constellation Pharmaceuticals Inc market cap is $1.63B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Constellation Pharmaceuticals Inc 52 week high is $39.30 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Constellation Pharmaceuticals Inc 52 week low is $17.00 as of November 20, 2026.
Constellation Pharmaceuticals Inc stock price today is $33.99.
Constellation Pharmaceuticals Inc stock price yesterday was $33.97.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Constellation Pharmaceuticals Inc's P/E ratio is -11.21.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Constellation Pharmaceuticals Inc P/B ratio is 4.3162.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Constellation Pharmaceuticals Inc 50-day moving average is $28.64.